Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell × daratumumab × Clear all

NCT04251065 2025-03-28

Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH

Phase 2 Terminated

8 enrolled 17 charts

Lymphoma, T-Cell